Correlation Between Sartorius Stedim and Mediantechn

Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and Mediantechn at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and Mediantechn into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sartorius Stedim Biotech and Mediantechn, you can compare the effects of market volatilities on Sartorius Stedim and Mediantechn and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of Mediantechn. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and Mediantechn.

Diversification Opportunities for Sartorius Stedim and Mediantechn

-0.08

Correlation Coefficient

Sartorius Stedim  Mediantechn

Good diversification

The 3 months correlation between Sartorius and Mediantechn is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and Mediantechn in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mediantechn and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with Mediantechn. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mediantechn has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and Mediantechn go up and down completely randomly.

Pair Corralation between Sartorius Stedim and Mediantechn

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to generate 0.68 times more return on investment than Mediantechn. However, Sartorius Stedim Biotech is 1.47 times less risky than Mediantechn. It trades about 0.03 of its potential returns per unit of risk. Mediantechn is currently generating about -0.19 per unit of risk. If you would invest  17,425  in Sartorius Stedim Biotech on September 5, 2024 and sell it today you would earn a total of  380.00  from holding Sartorius Stedim Biotech or generate 2.18% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Sartorius Stedim Biotech  vs.  Mediantechn

Sartorius Stedim Biotech

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong primary indicators, Sartorius Stedim is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Mediantechn

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mediantechn has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Sartorius Stedim and Mediantechn

The main advantage of trading using opposite Sartorius Stedim and Mediantechn positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, Mediantechn can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mediantechn will offset losses from the drop in Mediantechn's long position.

The idea behind Sartorius Stedim Biotech and Mediantechn pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.